The 21st International Congress of Therapeutic Drug Monitoring & Clinical Toxicology (IATDMCT 2023) will be held 24-27 September 2023 in Oslo, Norway. IATDMCT 2023 will be the most important opportunity for experts in Therapeutic Drug Monitoring and Clinical Toxicology from the world to meet and discuss the innovations and problems in the field.

Registration to the congress:

The deadline for early bird registration is June 15th.

The registration fees are not expensive as the local Norwegian currency, NOK, is a lower cost compared to USD or EU.

Accommodation for the congress: See info on the congress website.

Submitters of abstracts will be notified within a few days to inform whether presentation at the congress will be as oral or poster. At least one of the authors must register for the congress. This is a meeting in person only. The presentations will be at the congress venue.

The congress committee is planning for Breakfast roundtables. More information will appear on the website soon. Please contact us if you have a topic that you may want to lead yourself.

Congress website: iatdmct2023.org

Program details are currently also being updated on the website. The IATDMCT 2023 Congress offers an attractive opportunity for sponsors to interact with the attendees, and present their company, products and services. Please visit the website of the cCongress for more details if you are interested in sponsorship.

We are looking forward to seeing you in Oslo in September!

Stein Bergan (Congress Chair)

http://iatdmct2023.org/       IATDMCT@gyro.no

The special Membership Award includes free membership to IATDMCT & access to the TDM journal for a period of 2 years, renewable once. Several awards are available each year. Any IATDMCT member in good standing may nominate an individual from a designated developing country who is unable to afford the annual membership dues and Journal subscription. Applications should be submitted to the management office by October 31 of the year preceding the Award year.

Enjoy all the valuable Membership Benefits, including online access to the Therapeutic Drug Monitoring (TDM) journal.

Get the complete Terms of Reference and learn how to apply today.

Deadline: July 31, 2023

At the 2023 IATDMCT Congress in Oslo, the venue for the 2027 Congress will be chosen.

Members interested in submitting a proposal to host the Congress must submit an application by July 31, 2023. The purpose of this application is to provide guidance for candidates and to facilitate the task of selecting the final site, for the Site Selection Committee. You may choose to submit the information required on the application form in a different format, but all questions on the form should be addressed. Very often a tourism office, conference center, or hotel in the region can help you gather the information.

For more information on the application process, please contact: Congress Site Selection Committee

Click here to email your questions

IATDMCT members are invited to nominate individuals for the IATDMCT Council.

Current members of Council are eligible for election to another office or for one reelection to a second term in their current position. Only 2 terms may be served by any individual in any one post.

We are actively encouraging members to consider applying for:

• Director of Education (3 positions)

Nominations should be sent to Prof. Jan-Willem Alffenaar, President-Elect, c/o the IATDMCT Office (info@iatdmct.org).

Nominations from members must be accompanied by curriculum vitae and a letter of support from the nominator. Additional letters of support from IATDMCT members are welcome.

Professor Johannes (Jan-Willem) Alffenaar, PhD, PharmD, Clinical Pharmacologist
President-Elect, IATDMCT

Join us in maintaining the IATDMCT membership! We look forward to inspiring many further colleagues who share with us the idea of an optimized and personalized drug treatment to join us in IATDMCT. Please ensure you renew your membership in order to retain your IATDMCT member benefits.

Our 2023 Member-Get-A Member Campaign now is up and running! Members are invited to inform their colleagues (who are not members yet) about the benefits of membership. Let’s build a strong partnership together!

Campaign Deadline: August 31, 2023.

The top recruiter (with at least 50%-paying members) will gain a free registration for the IATDMCT Congress 2023 in Oslo.

Click here for complete participation details!

In this issue:

• Dear Friends and Colleagues
• Challenges and Solutions for the Increasing Use of Immune Checkpoint Inhibitors in Oncology
• Interpreting Pharmacogenetic Test Results: The *1/*1 Pitfall
• 2023 IATDMCT Member-Get-A-Member Campaign: The Competition Is On!
• Social Media Co-Managers Wanted!

Available in your choice of format:                  

Note: You must be logged in to access these download links.

Dr. Bénédicte Franck, University Hospital of Rennes, France, is a new Co Manager of Instagram and Dr. Miao Yan, Second Xiangya Hospital of Central South University, China is a new LinkedIN Manager.

Welcome to this team and thank you for your support!!

Dr. Bénédicte Franck	Dr. Miao Yan

Eight Drugs a Week – Episode 5 – TDM of antiretroviral drugs: The continuing story (of Bungalow Bill)...

This episode is about the TDM of antiretroviral drugs, an area with a boom in research output in the late 90s and early 2000s, generating enough randomized controls trials for a substantial systematic Cochrane review on the topic (a rare thing for TDM research!). It’s an ever-evolving space, but we have learned a lot through concentration monitoring, and TDM continues to be very useful in optimizing treatment. As our title suggests, this is a continuing story, and our guests, Natella Rakhmanina and Dario Cattaneo, have both been closely involved with it over their careers.

Join us every two months on your favourite podcast platform.

Find the latest news and follow our IATDMCT institutional page on LinkedIn, Twitter @IATDMCT or Instagram!

Stay ahead with the latest scientific research developments in the fields of TDM and CT!

The monthly Therapeutic Drug Monitoring column provides you with the latest posts of ahead-of-print. Bringing to you articles posted online April 20 – May 30, 2023:

ORIGINAL ARTICLES:

• Therapeutic Drug Monitoring of Perampanel in Children With Refractory Epilepsy: Focus on Influencing Factors on the Free-Perampanel Concentration
  Qu, Rui; Dai, Yuanyuan; Zhu, Zengyan; Lu, Xiaoyun; Zhou, Rui; Qu, Xiangju; Chen, Xuqin.
  April 20, 2023
• Developing a Method for Quantifying Meropenem in Children—Volumetric Adsorptive Microsampling Versus Plasma Sampling
  Ramadan, Ola; Schatz, Lea Marie; van den Heuvel, Ingeborg; Masjosthusmann, Katja; Groll, Andreas H.; Hempel, Georg.
  May 2, 2023
• In silico Evaluation of a Vancomycin Dosing Guideline Among Adults with Serious Infections
  Williams, Paul; Cotta, Menino Osbert; Abdul-Aziz, Mohd H.; Wilks, Kathryn; Farkas, Andras; Roberts, Jason A.
  May 2, 2023
• Variable Delta-9-Tetrahydrocannabinol Pharmacokinetics and Pharmacodynamics After Cannabis Smoking in Regular Users
  Liyanage, Marlon; Nikanjam, Mina; Capparelli, Edmund V.; Suhandynata, Raymond T.; Fitzgerald, Robert L.; Marcotte, Thomas D.; Grant, Igor; Momper, Jeremiah D.
  May 4, 2023
• Determination of Orelabrutinib in Human Plasma Using LC-MS/MS
  Zhao, Yang; Guo, Yu-Jiao; Chen, Xiang-Long; Yang, Yan-Ling; Ma, Hong; Wang, Yong-Qing; Sun, Lu-Ning
  May 5, 2023
• Stability of 10 Beta-Lactam Antibiotics in Human Plasma at Different Storage Conditions
  Bahmany, Soma; Ewoldt, Tim M.J.; Abdulla, Alan; Koch, Birgit C.P.
  May 9, 2023
• Busulfan Interlaboratory Proficiency Testing Program Revealed Worldwide Errors in Drug Quantitation and Dose Recommendations
  Kweekel, Dina M.; McCune, Jeannine S.; Punt, Arjen M.; van Luin, Matthijs; Franssen, Eric J.F.
  May 12, 2023
• Diverse Drug Classes Partition into Human Sweat: Implications for Both Sweat Fundamentals and for Therapeutic Drug Monitoring
  Ruwe, Theresa; White, Evyn; Zebertavage, Aidan S.; Runnoe, David; Fay, Dan; Daumeyer, Henry; Tracy, Timothy S.; Uchtman, Kara Fay; Begtrup, Gavi; Yuan, Yuchan; Heikenfeld, Jason; Buggele, William A.
  May 30, 2023

GRAND ROUNDS:

• Delayed Lithium Reintoxication in a Case of Severe Multidrug Intoxication: A Case Study
  Liang, Jiayi; van den Bout, Christiaan J.; Bosch, Tessa M.; Mitrov-Winkelmolen, Lieke.
  May 30, 2023

CASE REPORT:

• Cobicistat as a Potential Booster of Ponatinib and Dasatinib Exposure in a CML Patient: A Case Study
  Hofman, Susan; Touw, Daan J.; Span, Bart F. R.; Oude Munnink, Thijs H.
  May 30, 2023

LETTER TO THE EDITOR:

• Therapeutic Drug Monitoring Consulting Cannot be Ruled out by Model-Informed Precision Dosing
  Launay, Manon; Correia, Patricia; Thiery, Guillaume; Ragey, Sophie Perinel.
  May 23, 2023

››Submit your high quality research – Information for authors.

The Communication Committee would like to inform the membership that advertisements for professional positions (Ph.D. and Post-Doc job opportunities) in the field of TDM/CT, will be published in the E-news instead of on the IATDMCT website. Please e-mail the office with the advertisement for the position and it will be published in an upcoming monthly E-news. (IATDMCT office email: info@iatdmct.org)

The Communication Committee is also working in IATDMCT Website frames settings to provide better service to members.

We are inviting members interested to join Communication Committee to assist in the management of Social Media (Twitter and Website).

Please send an email to Dr. Ofelia Noceti (ofelianp@gmail.com) and Dr. Ryuji Kato (ryuji.kato@ompu.ac.jp), which include a resumed CV and explanatory note telling which area you would like to cooperate. We are looking forward to your candidates!

» Click here to Post an Event on our Online Events Calendar today!

Visit the IATDMCT Events Calendar and stay informed about the upcoming TDM and CT Meetings. By doing this you can comfortably and directly reach all related online resources.

The 39th annual meeting of the Japanese Society of Therapeutic Drug Monitoring (JSTDM) will be held on June 24th-25th, 2023 (Kyoto, Japan). JSTDM intends to organize the “JSTDM–IATDMCT Joint Symposium 2023 in Asia” as a part of scientific program of the above Congress. This symposium aims to share the latest research on therapeutic drug monitoring and to facilitate interaction between Asian scientists of JSTDM and IATDMCT.

The following three IATDMCT members from Malaysia, Thailand and India will participate in the symposium as speakers.

• Dr. Hannah Abdul Halim (Head of Clinical Pharmacokinetic Services, Pharmacy Department, Hospital Kuala Lumpur, Malaysia)
• Dr. Karunrat Tewthanom (Department of Pharmacy, Silpakorn University, Thailand)
• Dr. Sumith K Mathew (Associate professor, Christian Medical College, Vellore, India)
• Dr. Yasuhiro Horita (Lecturer, Nagoya City University, Nagoya, Japan)

June 24-28, 2023; Bellevue, Washington
Website: https://researchsocietyonalcohol.org/

The Society serves as a meeting ground for scientists and a forum for communication and career development among alcohol researchers. Its goals are to attract and support the next generation of alcohol researchers and to disseminate scientific knowledge regarding alcohol use and alcohol-related problems.

June 24, 2023 is the 17th Charles Lieber & 1st Peter Ferenci Memorial Symposium – Organizers Manuela Neuman and Helmut Seitz.

The 2023 Annual Meeting of American College of Clinical Pharmacology (ACCP) will be held on Sept 10-12, 2023 at the Hyatt Regency Bellevue, WA, USA. Looking forward to your participation! Registration is now open.

Co-editor: Manuela Neuman
Co-editor: Ryuji Kato
Co-editor: Miao Yan

NOTE: Items appearing in the IATDMCT monthly E-News do not necessarily have the endorsement of the Association.